Karhu Pharma Oy is a limited company based in Pori, registered in 2016. In the financial year ending 31.12.2025, revenue was 0 € and operating profit -1 659 €; equity ratio 99.8 %. Its taxable income in 2024 was 219 t€ and its income taxes 45 t€.
Revenue 20250 €-100 % on the previous year
Operating profit-1 659 €
Net profit33 t€EBITDA -1 659 €
Equity ratio99,8 %quick ratio 565,44
Taxable income 2024219 t€
top quarter of its industry
Income taxes 202445 t€497 t€ in 2020–2024
In business10 yrsregistered 11.8.2016
Pori: 17 new companies in 30 days
- Firmus Holding OyHoldingyhtiöiden toiminta
- Casa Valo OyElokuvien, videoiden ja televisio-ohjelmien tuotanto
- Porin Aurinkosähkö OySähköasennus
Try for free
Get your area's new companies by email every morning. 14 days, no card needed.
Financials
RevenueOperating profitNet profit
| Key figures | 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | 31.12.2021 | 31.12.2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 € | 1,2 M€ | 3,5 M€ | 3,5 M€ | 3,4 M€ | 2,7 M€ |
| Revenue change | -100,0 % | -66,4 % | 0,6 % | 0,1 % | 29,1 % | – |
| EBITDA | -1 659 € | 189 t€ | 575 t€ | 582 t€ | 558 t€ | 490 t€ |
| EBITDA % | – | 16,2 % | 16,6 % | 16,9 % | 16,2 % | 18,3 % |
| Operating profit | -1 659 € | 177 t€ | 570 t€ | 575 t€ | 549 t€ | 477 t€ |
| Operating margin | – | 15,2 % | 16,4 % | 16,7 % | 15,9 % | 17,9 % |
| Net profit | 33 t€ | 171 t€ | 488 t€ | 446 t€ | 447 t€ | 386 t€ |
| Personnel costs | -75 € | 116 € | 154 € | 135 € | 175 € | 154 € |
| Equity ratio | 99,8 % | 99,8 % | 97,1 % | 91,5 % | 93,9 % | 79,8 % |
| Quick ratio | 565,44 | 459,82 | 30,28 | 10,33 | 14,03 | 4,11 |
| Current ratio | 565,44 | 459,82 | 34,00 | 11,64 | 16,25 | 4,83 |
| Debt to revenue | – | 0,4 % | 2,1 % | 5,6 % | 3,3 % | 12,9 % |
| Return on equity | 1,4 % | 7,1 % | 20,4 % | 21,7 % | 25,5 % | 28,5 % |
| Balance sheet total | 2,3 M€ | 2,4 M€ | 2,5 M€ | 2,3 M€ | 1,9 M€ | 1,7 M€ |
| Equity | 2,3 M€ | 2,4 M€ | 2,4 M€ | 2,1 M€ | 1,8 M€ | 1,4 M€ |
| Cash and bank | 661 t€ | 953 t€ | 1,1 M€ | 219 t€ | 211 t€ | 103 t€ |
Balance sheet
Balance sheet totalEquityCash
Income statement and balance sheet
Income statement
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | 31.12.2021 | 31.12.2020 | |
|---|---|---|---|---|---|---|
| Turnover | 0 € | 1,2 M€ | 3,5 M€ | 3,5 M€ | 3,4 M€ | 2,7 M€ |
| Other operating income | 5 704 € | 0 € | – | – | – | – |
| Raw materials and services | 0 € | -776 t€ | -2,3 M€ | -2,2 M€ | -2,3 M€ | -1,7 M€ |
| Personnel expenses | 75 € | -116 € | -154 € | -135 € | -175 € | -154 € |
| Depreciations and reductions in value | 0 € | -12 t€ | -5 176 € | -6 901 € | -9 202 € | -12 t€ |
| Other operating expenses | 7 288 € | -202 t€ | -612 t€ | -627 t€ | -633 t€ | -512 t€ |
| Operating profit (loss) | -1 659 € | 177 t€ | 570 t€ | 575 t€ | 549 t€ | 477 t€ |
| Financial income and expenses + (-) | -41 t€ | 38 t€ | 37 t€ | -12 t€ | 8 871 € | 5 945 € |
| Profit (loss) before appropriations and taxes | 39 t€ | 215 t€ | 607 t€ | 564 t€ | 558 t€ | 483 t€ |
| Income taxes | 6 062 € | -44 t€ | -119 t€ | -117 t€ | -112 t€ | -97 t€ |
| Profit (loss) for the financial year | 33 t€ | 171 t€ | 488 t€ | 446 t€ | 447 t€ | 386 t€ |
Balance sheet
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | 31.12.2021 | 31.12.2020 | |
|---|---|---|---|---|---|---|
| Non-current assets | 100 € | 36 t€ | 16 t€ | 21 t€ | 28 t€ | 37 t€ |
| Stocks | – | 0 € | 268 t€ | 253 t€ | 252 t€ | 248 t€ |
| Receivables | 10 € | 1 881 € | 253 t€ | 1,3 M€ | 983 t€ | 1,1 M€ |
| Cash in hand and at banks | 661 t€ | 953 t€ | 1,1 M€ | 219 t€ | 211 t€ | 103 t€ |
| Current assets | 2,3 M€ | 2,4 M€ | 2,5 M€ | 2,2 M€ | 1,8 M€ | 1,7 M€ |
| Assets | 2,3 M€ | 2,4 M€ | 2,5 M€ | 2,3 M€ | 1,9 M€ | 1,7 M€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 2,3 M€ | 2,4 M€ | 2,4 M€ | 2,1 M€ | 1,8 M€ | 1,4 M€ |
| Short-term liabilities | 4 094 € | 5 193 € | 72 t€ | 192 t€ | 113 t€ | 344 t€ |
| Liabilities | 4 094 € | 5 193 € | 72 t€ | 192 t€ | 113 t€ | 344 t€ |
All financial statement items (47)
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | 31.12.2021 | 31.12.2020 | |
|---|---|---|---|---|---|---|
| Turnover | 0 € | 1,2 M€ | 3,5 M€ | 3,5 M€ | 3,4 M€ | 2,7 M€ |
| Other operating income | 5 704 € | 0 € | – | – | – | – |
| Raw materials and services | 0 € | -776 t€ | -2,3 M€ | -2,2 M€ | -2,3 M€ | -1,7 M€ |
| Personnel expenses | 75 € | -116 € | -154 € | -135 € | -175 € | -154 € |
| Depreciations and reductions in value | 0 € | -12 t€ | -5 176 € | -6 901 € | -9 202 € | -12 t€ |
| Other operating expenses | 7 288 € | -202 t€ | -612 t€ | -627 t€ | -633 t€ | -512 t€ |
| Operating profit (loss) | -1 659 € | 177 t€ | 570 t€ | 575 t€ | 549 t€ | 477 t€ |
| Financial income and expenses + (-) | -41 t€ | 38 t€ | 37 t€ | -12 t€ | 8 871 € | 5 945 € |
| Profit (loss) before appropriations and taxes | 39 t€ | 215 t€ | 607 t€ | 564 t€ | 558 t€ | 483 t€ |
| Income taxes | 6 062 € | -44 t€ | -119 t€ | -117 t€ | -112 t€ | -97 t€ |
| Profit (loss) for the financial year | 33 t€ | 171 t€ | 488 t€ | 446 t€ | 447 t€ | 386 t€ |
| Non-current assets | 100 € | 36 t€ | 16 t€ | 21 t€ | 28 t€ | 37 t€ |
| Stocks | – | 0 € | 268 t€ | 253 t€ | 252 t€ | 248 t€ |
| Receivables | 10 € | 1 881 € | 253 t€ | 1,3 M€ | 983 t€ | 1,1 M€ |
| Cash in hand and at banks | 661 t€ | 953 t€ | 1,1 M€ | 219 t€ | 211 t€ | 103 t€ |
| Current assets | 2,3 M€ | 2,4 M€ | 2,5 M€ | 2,2 M€ | 1,8 M€ | 1,7 M€ |
| Assets | 2,3 M€ | 2,4 M€ | 2,5 M€ | 2,3 M€ | 1,9 M€ | 1,7 M€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 2,3 M€ | 2,4 M€ | 2,4 M€ | 2,1 M€ | 1,8 M€ | 1,4 M€ |
| Short-term liabilities | 4 094 € | 5 193 € | 72 t€ | 192 t€ | 113 t€ | 344 t€ |
| Liabilities | 4 094 € | 5 193 € | 72 t€ | 192 t€ | 113 t€ | 344 t€ |
| Finished products | – | 0 € | 268 t€ | 253 t€ | 252 t€ | 248 t€ |
| Investments | 100 € | 100 € | 100 € | 100 € | 100 € | 0 € |
| Other short-term receivables | 10 € | 10 € | 233 t€ | 1,3 M€ | 929 t€ | 1,1 M€ |
| Other current liabilities | 0 € | 10 € | 30 t€ | 17 t€ | 30 t€ | 88 € |
| Retained earnings | 2,3 M€ | 2,2 M€ | 1,9 M€ | 1,6 M€ | 1,3 M€ | 967 t€ |
| Reductions in value of shares and holdings in current assets | -9 032 € | -4 821 € | 11 t€ | -23 t€ | 45 € | -1 288 € |
| Short-term prepayments and accrued income | 0 € | 1 871 € | 20 t€ | 1 592 € | 9 830 € | 9 468 € |
| Short-term accounts payable | – | 0 € | 37 t€ | 42 t€ | 74 t€ | 67 t€ |
| Short-term sales receivables | – | 0 € | 179 € | 92 € | 44 t€ | 5 188 € |
| Purchases during the financial year | 0 € | -508 t€ | -2,3 M€ | -2,2 M€ | -2,3 M€ | -1,7 M€ |
| Profit (loss) for the period, equity | 33 t€ | 171 t€ | 488 t€ | 446 t€ | 447 t€ | 386 t€ |
| Short-term receivables | 10 € | 1 881 € | 253 t€ | 1,3 M€ | 983 t€ | 1,1 M€ |
| Interest expenses and other financial expenses for non-Group companies | 3 791 € | -361 € | -990 € | -5 108 € | 0 € | -25 € |
| Tangible assets | 0 € | 36 t€ | 16 t€ | 21 t€ | 28 t€ | 37 t€ |
| Short-term accrued expenses and deferred income | 4 094 € | 5 183 € | 5 504 € | 132 t€ | 9 353 € | 277 t€ |
| Other shares, financial securities | 10 t€ | 10 t€ | 10 t€ | 10 t€ | 10 t€ | 0 € |
| Liabilities | 2,3 M€ | 2,4 M€ | 2,5 M€ | 2,3 M€ | 1,9 M€ | 1,7 M€ |
| Other interest and financial income from non-group companies | 35 t€ | 42 t€ | 27 t€ | 16 t€ | 8 826 € | 7 258 € |
| Other social security expenses | 75 € | -116 € | -154 € | -135 € | -175 € | -154 € |
| Machinery and equipment | 0 € | 36 t€ | 16 t€ | 21 t€ | 28 t€ | 37 t€ |
| Other shares and holdings | 1,6 M€ | 1,4 M€ | 821 t€ | 455 t€ | 384 t€ | 234 t€ |
| Shares and holdings | 1,7 M€ | 1,4 M€ | 831 t€ | 465 t€ | 394 t€ | 234 t€ |
| Depreciations according to plan | 0 € | -12 t€ | -5 176 € | -6 901 € | -9 202 € | -12 t€ |
| Inventory increase (+) or decrease (-) | 0 € | -268 t€ | 16 t€ | 1 098 € | 3 271 € | 56 t€ |
| Other shares and similar rights of ownership | 100 € | 100 € | 100 € | 100 € | 100 € | 0 € |
| Income from other investments under non-current assets, from other companies | 550 € | 450 € | 445 € | – | – | – |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, Karhu Pharma Oy is in the top quarter of the industry class other financial service activities, except insurance and pension funding n.e.c. (2751 companies with taxable income; median 21 t€, 11 times the median).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.